RecruitingNANCT07565714

Optimization of Late Imagery Rescripting Research Using Generative Artificial Intelligence

Sponsor: University of Social Sciences and Humanities, Warsaw

Trial Details

Condition	Generalized Anxiety, Fear of Failure, Rumination
Intervention	Imagery Rescripting Intervention
Phase	NA
Status	Recruiting
Participants	40
Est. Completion	1 June 2026
Last Updated	7 May 2026

Primary Outcome

Generalized Anxiety Disorder DSM Scale (GAD); The Performance Failure Appraisal Inventory; Intrusive Thought Frequency (Rumination Inventory - adapted); Skin Conductance Level (SCL); Emotional Response Ratings (Subjective)

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: - Age 18-35 - Score ≥ 8 on GAD-7 (Plummer et al., 2016) - Ability to recall at least two childhood memories involving parental criticism Exclusion Criteria: - History of prolonged physical or sexual abuse - Current psychotherapy or psychopharmacology - PTSD diagnosis (DSM-5 screening) - Substance abuse (TAPS tool)

Trial Sites

Countries

Poland

View Registry Entry

Related Analysis

Novel AI-Enhanced Imagery Rescripting Trial Opens for Generalized Anxiety — Exploring Digital Therapeutic Innovation

A groundbreaking clinical trial in Poland is investigating AI-enhanced imagery rescripting therapy for generalized anxiety disorder. The study examines whether artificial intelligence can optimize traditional psychotherapy techniques for treating anxiety, fear of failure, and rumination.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service